REGEN BIOPHARMA, INC. Accrued Investment Income Receivable
REGEN BIOPHARMA, INC. (RGBP) had Accrued Investment Income Receivable of $0 as of 2023-06-30, per its 10-Q filed 2023-07-25.
Discontinued › Balance Sheet › Assets
us-gaap:AccruedInvestmentIncomeReceivable · last filed 2023-07-25
- 2023-06-30: Accrued Investment Income Receivable $0.00.
- 2022-12-31: Accrued Investment Income Receivable $0.00.
- 2022-09-30: Accrued Investment Income Receivable $0.00.
- 2022-06-30: Accrued Investment Income Receivable $629.00.
| Period end | Accrued Investment Income Receivable |
|---|---|
| 2023-06-30 | $0.00 10-Q · filed 2023-07-25 |
| 2022-12-31 | $0.00 10-Q · filed 2023-01-19 |
| 2022-09-30 | $0.00 10-Q · filed 2023-07-25 |
| 2022-06-30 | $629.00 10-Q · filed 2022-07-22 |
| 2022-03-31 | $496.00 10-Q · filed 2022-04-21 |
| 2021-12-31 | $365.00 10-Q · filed 2022-01-20 |
| 2021-09-30 | $230.00 10-K · filed 2022-11-15 |
| 2021-06-30 | $96.00 10-Q/A · filed 2021-12-22 |
| 2020-09-30 | $0.00 10-Q/A · filed 2021-12-22 |